Myeloma research group
Organisational unit: Research group
Research areas and keywords
UKÄ subject classification
- myeloma, phagocyte, eosinophils, neutrophils , plasma cells, clinical trial
Our main aim is to improve outcome for the painful and fatal tumor disease, multiple myeloma (MM). To do this we pursue three lines of research; i) use investigator initiated clinical trials to test prevention strategies and ii) test new drug combinations in clinical trials and iii) investigate phagocyte subsets and functions during treatment and progression of MM.
Recent research outputs
Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in SwedenAli, M., Konstantinos Lemonakis, Anna-Karin Wihlborg, Veskovski, L., Ingemar Turesson, Mellqvist, U-H., Urban Gullberg, Markus Hansson & Björn Nilsson, 2019 Jul 30, In : Blood Cancer Journal. 9, 8, 57.
Research output: Contribution to journal › Letter
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myelomaDimopoulos, M. A., Grosicki, S., Jędrzejczak, W. W., Nahi, H., Gruber, A., Markus Hansson, Gupta, N., Byrne, C., Labotka, R., Teng, Z., Yang, H., Grzasko, N. & Kumar, S., 2019, In : European Journal of Cancer. 106, p. 89-98 10 p.
Research output: Contribution to journal › Article
View All (23)